Telefonas, MB - financials and debts

Company age: 3 y. 10 mo.

Update

Telefonas - Company finances

EUR
2022
From: 2022-11-15
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue - 778 3,790 2,802
Profit before tax - -789 -251 1,397
Net profit -5 -789 -251 1,376
Equity -5 -793 -1,039 337
Liabilities 5 1,206 1,444 972
Non-current assets 0 0 0 0
Current assets 0 413 405 1,309
Total assets 0 413 405 1,309
Taxes paid
STI taxes - 109 457 501
Financial indicators
Revenue change y/y - - +387.1% -26.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. - -191.0% -62.0% 105.1%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - - - 408.3%
Profit margin Net profit margin. Shows the overall profitability of the company. - -101.4% -6.6% 49.1%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - -101.4% -6.6% 49.9%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - - 2.9
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Telefonas - Social security debts

From To Debt, €
2023-06-02 2023-06-30 117.26
2023-06-01 2023-06-01 175.89
2023-05-04 2023-05-31 117.26
2023-05-02 2023-05-03 58.63
2023-04-03 2023-04-30 58.63

Telefonas - VMI tax arrears

From To Overdue, €
2026-01-01 2026-01-13 9.43

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Telefonas, MB (code 306178112) is a Small partnership engaged in other non-specialised retail sale. In the latest financial year, 2025, the company generated EUR 2.8K in revenue and recorded net profit of EUR 1.4K, which resulted in a strong profit margin of 49.1%. Revenue decreased by 26.1% year on year from 2024, but it remained above the 2023 level and was up materially over the two-year period. The trajectory shows revenue rising from EUR 778 in 2023 to EUR 3.8K in 2024, then easing in 2025. Profitability improved significantly over the period: net loss of EUR 789 in 2023 narrowed to a loss of EUR 251 in 2024, before turning into profit in 2025. At year-end 2025, total assets stood at EUR 1.3K, equity at EUR 337 and liabilities at EUR 972. The balance sheet remains small, and leverage is visible, with debt-to-equity at 2.88 and an equity ratio of 25.7%. Asset turnover was 2.14x, indicating efficient use of a compact asset base.